Laura Bui

Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity

Cancer to bone: a fatal attraction

Molecular mechanisms of epithelial–mesenchymal transition

Targeting Ferroptosis to Iron Out Cancer

A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression

Mammalian lipoxygenases and their biological relevance

Epidemiology of Prostate Cancer

Unleashing the therapeutic potential of human kallikrein-related serine proteases

Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold – A Potential Therapeutic Intervention for Skin Diseases

Receptor activator of NF-κB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells

1,2,4-Oxadiazoles: A new class of anti-prostate cancer agents

Transforming Growth Factor-β1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro

Kallikrein-related Peptidase 4 (KLK4) Initiates Intracellular Signaling via Protease-activated Receptors (PARs)

Ferroptosis: mechanisms, biology and role in disease

Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals

TGF-β-induced epithelial to mesenchymal transition

Variants of the hK2 Protein Gene (KLK2) Are Associated with Serum hK2 Levels and Predict the Presence of Prostate Cancer at Biopsy

Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box

Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis

Novel transglutaminase 1 mutations in patients affected by lamellar ichthyosis

Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells